An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R. Good, Carl H. June, Philipp C. Rommel et al.|Cell|2021Cited by 398
Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapyNils Wellhausen, Carl H. June, Sangya Agarwal et al.|Current Opinion in Immunology|2021Cited by 22
Application of Traditional Vaccine Development Strategies to SARS-CoV-2Halie M. Rando, Sandipan Ray, Ronan Lordan et al.|mSystems|2023Cited by 22
Production of Human CRISPR-Engineered CAR-T CellsSangya Agarwal, Carl H. June, Nils Wellhausen et al.|Journal of Visualized Experiments|2021Cited by 19
Epitope Editing in Hematopoietic Cells Enables CD45-Directed Immune TherapyNils Wellhausen, Saar Gill, Austin K. Rennels et al.|Blood|2022Cited by 9